CNS Pharmaceuticals
Stock Forecast, Prediction & Price Target
CNS Pharmaceuticals Financial Estimates
CNS Pharmaceuticals Revenue Estimates
CNS Pharmaceuticals EBITDA Estimates
CNS Pharmaceuticals Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $23.19M Low: $23.19M High: $23.19M avg. 0% | Avg: $40.75M Low: $40.75M High: $40.75M avg. 75.69% | Avg: $83.98M Low: $83.98M High: $83.98M avg. 106.04% | |
Net Income
% change YoY
| $-14.04M N/A | $-15.28M -8.79% | $-18.85M -23.36% | Avg: $-41.90M Low: $-919.24K High: $-919.24K avg. -122.27% | Avg: $-19.17M Low: $-19.17M High: $-19.17M avg. 54.23% | Avg: $11.30M Low: $11.30M High: $11.30M avg. 158.93% | |
EBITDA
% change YoY
| $-14.01M N/A | $-15.25M -8.85% | $-18.86M -23.63% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$15.99 N/A | -$11.22 29.83% | -$251.35 -2140.19% | Avg: -$12.2 Low: -$12.2 High: -$12.2 avg. 95.14% | Avg: -$254.5 Low: -$254.5 High: -$254.5 avg. -1986.06% | Avg: $150 Low: $150 High: $150 avg. 158.93% | |
Operating Expenses
% change YoY
| $14.02M N/A | $15.26M 8.83% | $18.86M 23.56% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is CNS Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 30.29% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -919.24K, average is -41.90M and high is -919.24K.
What is CNS Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 60.57% in 2025-2027.
We have gathered data from N/A analysts. Their low revenue estimate is $23.19M, average is $23.19M and high is $23.19M.
What is CNS Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -577.32% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$12.2, average is -$12.2 and high is $-12.2.